116 related articles for article (PubMed ID: 8752843)
1. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy.
Stringer MR; Collins P; Robinson DJ; Stables GI; Sheehan-Dare RA
J Invest Dermatol; 1996 Jul; 107(1):76-81. PubMed ID: 8752843
[TBL] [Abstract][Full Text] [Related]
2. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis.
Smits T; Kleinpenning MM; van Erp PE; van de Kerkhof PC; Gerritsen MJ
Br J Dermatol; 2006 Aug; 155(2):429-36. PubMed ID: 16882185
[TBL] [Abstract][Full Text] [Related]
4. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy.
Collins P; Robinson DJ; Stringer MR; Stables GI; Sheehan-Dare RA
Br J Dermatol; 1997 Nov; 137(5):743-9. PubMed ID: 9415234
[TBL] [Abstract][Full Text] [Related]
5. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
6. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy.
Robinson DJ; Collins P; Stringer MR; Vernon DI; Stables GI; Brown SB; Sheehan-Dare RA
Acta Derm Venereol; 1999 Nov; 79(6):451-5. PubMed ID: 10598759
[TBL] [Abstract][Full Text] [Related]
7. PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination.
Thissen MR; de Blois MW; Robinson DJ; de Bruijn HS; Dutrieux RP; Star WM; Neumann HA
J Invest Dermatol; 2002 Feb; 118(2):239-45. PubMed ID: 11841539
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.
Kleinpenning MM; Smits T; Ewalds E; van Erp PE; van de Kerkhof PC; Gerritsen MJ
Br J Dermatol; 2006 Sep; 155(3):539-45. PubMed ID: 16911278
[TBL] [Abstract][Full Text] [Related]
9. Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques.
Bissonnette R; Tremblay JF; Juzenas P; Boushira M; Lui H
J Invest Dermatol; 2002 Jul; 119(1):77-83. PubMed ID: 12164928
[TBL] [Abstract][Full Text] [Related]
10. Induction of protoporphyrin IX by aminolaevulinic acid in actinic keratosis, psoriasis and normal skin: preferential porphyrin enrichment in differentiated cells.
Smits T; van Laarhoven AI; Staassen A; van de Kerkhof PC; van Erp PE; Gerritsen MJ
Br J Dermatol; 2009 Apr; 160(4):849-57. PubMed ID: 19175603
[TBL] [Abstract][Full Text] [Related]
11. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin.
Van der Veen N; De Bruijn HS; Star WM
Int J Cancer; 1997 Jul; 72(1):110-8. PubMed ID: 9212231
[TBL] [Abstract][Full Text] [Related]
12. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
13. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
14. Study of protoporphyrin IX (PpIX) pharmacokinetics after topical application of 5-aminolevulinic acid in urethral condylomata acuminata.
Wang XL; Wang HW; Huang Z; Stepp H; Baumgartner R; Dannecker C; Hillemanns P
Photochem Photobiol; 2007; 83(5):1069-73. PubMed ID: 17880502
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder.
Leveckis J; Burn JL; Brown NJ; Reed MW
J Urol; 1994 Aug; 152(2 Pt 1):550-3. PubMed ID: 8015110
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior.
Fang YP; Huang YB; Wu PC; Tsai YH
Eur J Pharm Biopharm; 2009 Nov; 73(3):391-8. PubMed ID: 19660544
[TBL] [Abstract][Full Text] [Related]
17. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
18. Photosensitization of the endometrium with topical 5-aminolevulinic acid.
Gannon MJ; Johnson N; Roberts DJ; Holroyd JA; Vernon DI; Brown SB; Lilford RJ
Am J Obstet Gynecol; 1995 Dec; 173(6):1826-8. PubMed ID: 8610770
[TBL] [Abstract][Full Text] [Related]
19. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo.
Zenzen V; Zankl H
Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
